Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Jul 13, 2022 12:29pm
100 Views
Post# 34821145

RE:RE:RE:RE:10%

RE:RE:RE:RE:10%Which assets are pledged ? The PR does not mention ...I suspect that the is a Floating Charge on all the assets of the Company....If everything goes right all is OK If not we all get diluted by up to 100%...Russian roulette ? I hope not ......Would love to see THTX assumptions in entering  this deal .....Blind faith ...

palinc2000 wrote: SOFR IS 1,54% ADD 9.50 % ...This gives initial rate at 11.04%  which will go up as the SOPR rate goes up maybe above 2,5%

palinc2000 wrote: my first  read is interest rate over 11%   which indicates junk territory....

SPCEO1 wrote: The agreed interest rate is 0% for the first 2, possibly 3 years.

canadapiet wrote: They are paying more then 10% !!!!!
Ok,no dilution for now, but a lot of intrest to pay. 
Positive that such an institution believes in their future.

So i rebought a piece of the shares i sold at 3,30 CAD.

GLA

 

 




<< Previous
Bullboard Posts
Next >>